British Journal of Cancer

TABLE 2

FROM:

Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions

R M Pijnappel, M van den Donk, R Holland, W P Th M Mali, J L Peterse, J H C L Hendriks and P H M Peeters

BACK TO ARTICLE

Table 2. Characteristics of the study population

 Total populationUMCUUMCNAvL
Number of patients718202237279
Number of lesions749211255283
     
Age (range)54.7 (21–85)52.8 (24–85)54.8 (26–84)55.9 (21–83)
     
Reason for examination    
 Screen-detected lesions208 (27.8)56 (26.5)90 (35.3)62 (21.9)
 Family history of breast cancer98 (13.6)27 (13.4)49 (20.7)22 (7.9)
 History of breast cancer136 (18.9)33 (16.3)39 (16.5)64 (22.9)
 Othera 155 (21.6)58 (28.7)54 (22.8)43 (15.4)
 Unknown152 (21.2)37 (18.3)23 (9.7)92 (32.9)
     
Mammography729 (97.3)208 (98.6)245 (96.1)276 (97.5)
 Only microcalcifications223 (30.6)63 (30.3)73 (29.7)87 (31.5)
 Density with microcalcifications85 (11.7)18 (8.7)33 (13.5)34 (12.3)
 Density252 (34.5)72 (34.6)81 (33.1)99 (35.9)
 Spiculated density96 (13.2)22 (10.5)32 (13.1)42 (15.3)
 Focal asymmetry3 (0.4)1 (0.5)2 (0.8)0
 Architectural distortion12 (1.6)1 (0.5)9 (3.7)2 (0.7)
 Not visible56 (7.7)31 (14.9)15 (6.1)10 (3.6)
 Unknown2 (0.3)002 (0.7)
     
Ultrasonography    
 Number (% of lesion per clinic)567 (75.7)135 (64.0)202 (79.2)230 (81.3)
 Solid410 (72.3)110 (81.5)128 (63.4)172 (74.8)
 Both solid and cystic16 (2.8)6 (4.4)7 (3.5)3 (1.3)
 Not described16 (2.8)1 (0.7)8 (3.9)7 (3.0)
 Not visible125 (22.1)18 (13.4)59 (29.2)48 (20.9)
     
Radiologic diameter of lesion    
 No. of cases known (%)450 (60.1)84 (39.8)169 (66.3)197 (69.6)
 mm (s.d.)13.9 (10.8)10.9 (5.3)16.3 (12.7)13.0 (10.3)
     
Primary diagnostic intervention    
 Diagnostic surgery316 (42.2)79 (37.4)129 (50.6)108 (38.2)
 FNA ultrasound guided242 (32.3)72 (34.1)0170 (60.1)
 LCNB ultrasound guided128 (17.1)21 (10.0)102 (40.0)5 (1.7)
 LCNB stereotactic guided63 (8.4)39 (18.5)24 (9.4)0
     
Malignant lesions (histology)b 378 (50.4)84 (39.8)130 (50.9)164 (57.9)
 DCIS102 (27.0)26 (31.0)34 (26.2)42 (25.6)
 Invasive carcinoma276 (73.0)58 (69.0)96 (73.8)122 (74.4)

a Includes: palpable lesion somewhere else in the breast(s), follow-up for benign condition in the past, pain, hormone replacement therapy.

b Histology report from surgical specimen ('Gold standard')

BACK TO ARTICLE